| 1. |
Handy DE, Loscalzo J. Homocysteine and atherothrombosis:diagnosis and treatment[J].Curr Atheroscler Rep,2003,5:276-283.
|
| 2. |
Falk E, Zhou J, Moller J. Homocysteine and atherothrombosis[J].Lipids,2001,36 Suppl:S3-11.
|
| 3. |
Dietrich M, Jacques PF, Polak JF, et al. Segment-specific association between plasma homocysteine level and carotid artery intima-media thickness in the Framingham Offspring Study[J].J Stroke Cerebrovasc Dis,2011,20:155-161.
|
| 4. |
Tseng YL, Chang YY, Liu JS, et al. Association of plasma homocysteine concentration with cerebral white matter hyperintensity on magnetic resonance images in stroke patients[J].J Neurol Sci,2009,284:36-39.
|
| 5. |
Terelak-Borys B, Skonieczna K, Grabska-Liberek I. Ocular ischemic syndrome-a systematic review[J].Med Sci Monit,2012,18:138-144.
|
| 6. |
de Lau LM, van Meurs JB, Uitterlinden AG, et al. Genetic variation in homocysteine metabolism, cognition, and white matter lesions[J].Neurobiol Aging,2010,31:2020-2022.
|
| 7. |
Williams KT, Schalinske KL. New insights into the regulation of methyl group and homocysteine metabolism[J].J Nutr,2007,137:311-314.
|
| 8. |
Ueland PM, Refsum H, Stabler SP, et al. Total homocysteine in plasma or serum:methods and clinical applications[J]. Clin Chem,1993,39:1764-1779.
|
| 9. |
Smulders YM, den Heijer M, Blom HJ. Homocysteine levels:measure or not?[J]. Ned Tijdschr Geneeskd,2013,157:6265.
|
| 10. |
McCully KS. Vascular pathology of homocysteinemia:implications for the pathogenesis of arteriosclerosis[J].Am J Pathol,1969,56:111-128.
|
| 11. |
Lentz SR. Mechanisms of homocysteine-induced atherothrombosis[J].J Thromb Haemost,2005,3:1646-1654.
|
| 12. |
Signorello MG, Segantin A, Passalacqua M, et al. Homocysteine decreases platelet NO level via protein kinase C activation[J].Nitric Oxide,2009,20:104-113.
|
| 13. |
Stangl V, Gunther C, Jarrin A, et al. Homocysteine inhibits TNF-alpha-induced endothelial adhesion molecule expression and monocyte adhesion via nuclear factor-kappaB dependent pathway[J].Biochem Biophys Res Commun,2001,280:1093-1100.
|
| 14. |
Doshi SN, McDowell IF, Moat SJ, et al. Folate improves endothelial function in coronary artery disease:an effect mediated by reduction of intracellular superoxide?[J].Arterioscler Thromb Vasc Biol,2001,21:1196-1202.
|
| 15. |
Hossain, GS, van Thienen JV, Werstuck GH, et al.TDAG51 is induced by homocysteine, promotes detachment-mediated programmed cell death, and contributes to the cevelopment of atherosclerosis in hyperhomocysteinemia[J].J Biol Chem,2003,278:30317-30327.
|
| 16. |
Aguilar B, Rojas JC, Collados MT. Metabolism of homocysteine and its relationship with cardiovascular disease[J].J Thromb Thrombolysis,2004,18:75-87.
|
| 17. |
Bostom AG, Shemin D, Lapane KL, et al. Hyperhomocysteinemia, hyperfibrinogenemia, and lipoprotein (a) excess in maintenance dialysis patients:a matched case-control study[J].Atherosclerosis,1996,125:91-101.
|
| 18. |
Wang YL, Zhao L, and Li MM. Improved circulation in ocular ischemic syndrome after carotid artery stenting[J].Chin Med J(Engl),2011,124:3598-3600.
|
| 19. |
Luo RJ, Liu SR, Li XM, et al. Fifty-eight cases of ocular ischemic diseases caused by carotid artery stenosis[J].Chin Med J(Engl),2010,123:2662-2665.
|
| 20. |
Mendrinos E, Machinis TG, Pournaras CJ. Ocular ischemic syndrome[J].Surv Ophthalmol,2010,55:2-34.
|
| 21. |
Kearns TP, Hollenhorst RW.Venous-stasis retinopathy of occlusive disease of the carotid artery[J].Proc Staff Meet Mayo Clin,1963,38:304-312.
|
| 22. |
Kearns TP, Siekert RG, Sundt TM. The ocular aspects of carotid artery bypass surgery[J].Trans Am Ophthalmol Soc,1978,76:247-265.
|
| 23. |
Klijn CJ, Kappelle LJ, van Schooneveld MJ, et al. Venous stasis retinopathy in symptomatic carotid artery occlusion:prevalence, cause, and outcome[J].Stroke,2002,33:695-701.
|
| 24. |
Costa VP, Kuzniec S, Molnar LJ, et al.Collateral blood supply through the ophthalmic artery:a steal phenomenon analyzed by color doppler imaging[J].Ophthalmology,1998,105:689-693.
|
| 25. |
Kerty E, Eide N, Horven I. Ocular hemodynamic changes in patients with high-grade carotid occlusive disease and development of chronic ocular ischaemia Ⅱ:clinical findings[J].Acta Ophthalmol Scand,1995,73:72-76.
|
| 26. |
Sivalingam A, Brown GC, Magargal LE, et al. The ocular ischemic syndrome Ⅱ:mortality and systemic morbidity[J].Int Ophthalmol,1989,13:187-191.
|
| 27. |
Ebbing M, Bonaa KH, Arnesen E, et al. Combined analyses and extended follow-up of two randomized controlled homocysteine-lowering B-vitamin trials[J].J Intern Med,2010,268:367-382.
|
| 28. |
Cabezas-Leon MM, Garcia-Montero MR, Morente-Matas P. Hyperhomocysteinemia as a risk factor for central retinal vein thrombosis in a young patient[J].Rev Neurol,2003,37:441-443.
|
| 29. |
Weger M, Stanger O, Deutschmann H, et al. Hyperhomocyst(e)inemia, but not methylenetetrahydrofolate reductase C677T mutation, as a risk factor in branch retinal vein occlusion[J].Ophthalmology,2002,109:1105-1109.
|
| 30. |
Hong IH, Ahn JK, Chang S, et al. Diagnostic efficacy of total homocysteine and C-reactive protein for ocular ischemic syndrome[J].Eye (Lond),2011,25:1650-1654.
|
| 31. |
Ashjazadeh N, Fathi M, Shariat A. Evaluation of homocysteine level as a risk factor among patients with ischemic stroke and its subtypes[J].Iran J Med Sci,2013,38:233-239.
|
| 32. |
Turaj W, Iskra T, Pulyk R, et al.Plasma homocysteine concentration in patients with ischaemic stroke caused by large or small vessel disease[J].Pol Merkur Lekarski,2009,26:121-124.
|
| 33. |
Mahalle N, Kulkarni MV, Garg MK, et al. Vitamin B12 deficiency and hyperhomocysteinemia as correlates of cardiovascular risk factors in Indian subjects with coronary artery disease[J].J Cardiol,2013,61:289-294.
|
| 34. |
Ji Y, Tan S, Xu Y, et al. Vitamin B supplementation, homocysteine levels, and the risk of cerebrovascular disease:a meta-analysis[J].Neurology,2013,81:1298-1307.
|
